United Kingdom · Series A startup

Who invested in Immutrin

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$87Mraised across 1 round since 2026, from 1 source

Latest round
Series A, $87MMar 2026
Investors
3
See who backed them

The rounds

  1. Mar 2026
    Series A$87M

    Source recorded

Founders and team

From Immutrin's own website: 14 on the team.

  • Mihriban TunaCEO
  • Tolga HassanCFO & COO
  • Ali MuradVP Clinical Development
  • Kin Mei LeungVP R&D
  • Shobhal PatelVP Clinical Operations
  • Sef KurstjensChair
  • Alex Sinclair-WilsonTeam
  • James N. TopperTeam
  • Lin MuTeam
  • Mahesh KudariTeam
  • Martin TaylorTeam
  • Mike AnsteyTeam
  • Nihal SinhaTeam
  • Remus WongTeam

Everyone who backed them

ParkwalkVC firm1round
SR OneCorporate VC1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Immutrin as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Frazier Life SciencesVC firmPer its own site

Quick answers about Immutrin

Who invested in Immutrin?

Immutrin's investors include Qiming Venture Partners, Parkwalk and SR One.

How much has Immutrin raised?

Immutrin has raised $87M across 1 round since 2026.

When did Immutrin last raise?

Immutrin's most recent round was a Series A of $87M in Mar 2026.

What was Immutrin's biggest round?

Its most recent round, $87M in Mar 2026, is also its largest on record.

Who backed Immutrin first?

Immutrin's first round on record, in Mar 2026, was backed by Qiming Venture Partners, Parkwalk and SR One.

What stage is Immutrin at?

Immutrin's latest named round is a Series A, in Mar 2026.

Where is Immutrin based?

Immutrin is based in the United Kingdom.

Companies like Immutrin

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.